Q32 Bio (QTTB) Total Non-Current Liabilities (2022 - 2026)

Q32 Bio's Total Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $17.4 million for Q1 2026.

• In Q1 2026, Total Non-Current Liabilities fell 38.18% year-over-year to $17.4 million; the TTM figure through Mar 2026 stood at $17.4 million (down 38.18% YoY), while the FY2025 annual figure was $19.8 million, down 37.57% from the prior year.
• Total Non-Current Liabilities was $17.4 million for Q1 2026 at Q32 Bio, down from $19.8 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $48.5 million in Q1 2024 to a low of $17.4 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $30.7 million across 5 years, with a median of $31.2 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Total Non-Current Liabilities rose 13.57% in 2023, then slumped 42.04% in 2025.
• A 5-year view of Total Non-Current Liabilities shows it stood at $37.7 million in 2022, then rose by 13.57% to $42.8 million in 2023, then fell by 26.1% to $31.7 million in 2024, then sank by 37.57% to $19.8 million in 2025, then retreated by 12.14% to $17.4 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $17.4 million (Q1 2026), $19.8 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.